Clinical Trial Designs for Cytostatic Agents
- 15 June 2001
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (12) , 3154-3155
- https://doi.org/10.1200/jco.2001.19.12.3154
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Clinical Trial Designs for Cytostatic Agents: Are New Approaches Needed?Journal of Clinical Oncology, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Development of Target-Based Antineoplastic AgentsInvestigational New Drugs, 2000
- Statistical and Ethical Issues in the Design and Conduct of Phase I and II Clinical Trials of New Anticancer AgentsJNCI Journal of the National Cancer Institute, 1993
- Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trialJournal of the American College of Cardiology, 1993
- Randomized discontinuation trials: Utility and efficiencyJournal of Clinical Epidemiology, 1993